Page last updated: 2024-08-17

trifluoroacetic acid and antarelix

trifluoroacetic acid has been researched along with antarelix in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Godsafe, Z; Larsen, F; MacLean, CM; Soto-Forte, P1

Trials

1 trial(s) available for trifluoroacetic acid and antarelix

ArticleYear
Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin-Releasing Hormone Antagonist, in Healthy Adult Subjects.
    Clinical pharmacology in drug development, 2022, Volume: 11, Issue:2

    Topics: Aged; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Male; Oligopeptides; Trifluoroacetic Acid

2022